Chemistry:Sabcomeline
From HandWiki
Short description: Chemical compound
 | |
| Clinical data | |
|---|---|
| ATC code |
|
| Legal status | |
| Legal status |
|
| Identifiers | |
| |
| CAS Number |
|
| PubChem CID | |
| IUPHAR/BPS | |
| ChemSpider | |
| UNII |
|
| ChEMBL | |
| Chemical and physical data | |
| Formula | C10H15N3O |
| Molar mass | 193.250 g·mol−1 |
| 3D model (JSmol) | |
| |
Sabcomeline (Memric; SB-202,026) is a selective M1 receptor partial agonist that was under development for the treatment of Alzheimer's disease.[1] It made it to phase III clinical trials before being discontinued due to poor results.
See also
References
- ↑ "SB 202026: a novel muscarinic partial agonist with functional selectivity for M1 receptors". The Journal of Pharmacology and Experimental Therapeutics 283 (3): 1059–68. December 1997. PMID 9399977. http://jpet.aspetjournals.org/cgi/pmidlookup?view=long&pmid=9399977.
 |  |
